Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Cardiovascular Disease Risk Prediction Models: Challenges and Perspectives Publisher Pubmed



Farzadfar F1
Authors

Source: The Lancet Global Health Published:2019


Abstract

[No abstract available]
Related Docs
View other Related Docs
1. Evaluation of the Effectiveness of the Iran-Package of Essential Non-Communicable Disease (Irapen) Program in Reducing Cardiovascular Disease Risk in Pilot Areas, BMC Public Health (2025)
2. Prediction of Cardiovascular Disease Mortality in a Middle Eastern Country: Performance of the Globorisk and Score Functions in Four Population-Based Cohort Studies of Iran, International Journal of Health Policy and Management (2022)
3. Predicted 10-Year Risk of Cardiovascular Disease in the Islamic Republic of Iran and the Body Mass Index Paradox; [Prediction Du Risque De Maladie Cardio-Vasculaire Sur Une Periode De 10 Ans En Republique Islamique D'iran, Et Paradoxe De L'indice De Masse Corporelle], Eastern Mediterranean Health Journal (2020)
Experts (# of related papers)
View all Related Experts
Farshad Farzadfar (5)
Akram Pourshams (5)
Other Related Docs
4. Cardiovascular Mortality in a Western Asian Country: Results From the Iran Cohort Consortium, BMJ Open (2018)
5. Adherence to Iran’S Package of Essential Noncommunicable Diseases (Irapen) Program for Regular Follow-Up to Reduce the Risk of Cardiovascular Disease in Healthcare Centers, Iranian Journal of Endocrinology and Metabolism (2020)
6. Hypertension Care Cascades and Reducing Inequities in Cardiovascular Disease in Low- and Middle-Income Countries, Nature Medicine (2024)
7. Variation in the Proportion of Adults in Need of Blood Pressure-Lowering Medications by Hypertension Care Guideline in Low- and Middle-Income Countries a Cross-Sectional Study of 1 037 215 Individuals From 50 Nationally Representative Surveys, Circulation (2021)
8. Development of a Cvd Mortality Risk Score Using Nutritional Predictors: A Risk Prediction Model in the Golestan Cohort Study, Nutrition, Metabolism and Cardiovascular Diseases (2025)
9. Performance of the Revised World Health Organization Cardiovascular Disease Risk Prediction Models for the Middle East and North Africa: A Validation Study in the Tehran Lipid and Glucose Study, Journal of Clinical Epidemiology (2025)
10. The Burden of Cardiovascular Disease Attributable to Modifiable Risk Factors and Cost-Effectiveness Analysis of Irapen Program in the General Population of Iran, Medical Journal of the Islamic Republic of Iran (2022)
11. An Office-Based Cardiovascular Prediction Model Developed and Validated in Cohort Studies of a Middle-Income Country, Journal of Clinical Epidemiology (2022)
12. The State of Diabetes Treatment Coverage in 55 Low-Income and Middle-Income Countries: A Cross-Sectional Study of Nationally Representative, Individual-Level Data in 680 102 Adults, The Lancet Healthy Longevity (2021)
13. Polypill for the Prevention of Cardiovascular Disease (Polyiran): Study Design and Rationale for a Pragmatic Cluster Randomized Controlled Trial, European Journal of Preventive Cardiology (2015)
14. Risk of Incident Cardiovascular Diseases at National and Subnational Levels in Iran From 2000 to 2016 and Projection Through 2030: Insights From Iran Steps Surveys, PLoS ONE (2023)
15. Validity of the Models Predicting 10-Year Risk of Cardiovascular Diseases in Asia: A Systematic Review and Prediction Model Metaanalysis, PLoS ONE (2023)